Drug Delivery Strategies to Cross, Target, or Bypass the Blood–Brain Barrier
- 3 November 2025
- journal article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22 (11) , 6395-6397
Abstract
No abstract availableFunding Information
- National Institutes of Health/National Institute of Neurological Disorders and Stroke/National Institute for Aging (R01NS125437)
This publication has 20 references indexed in Scilit:
- Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentrationNeurotherapeutics, 2024
- Diblock Copolymers of Poly(ethylene oxide)-b-poly(propylene oxide) Stabilize a Blood–Brain Barrier Model under Oxidative StressMolecular Pharmaceutics, 2024
- Small Scale, Big Impact: Nanotechnology-Enhanced Drug Delivery for Brain DiseasesMolecular Pharmaceutics, 2024
- Potentiation of Brain Bioavailability Using Thermoreversible Cubosomal FormulationMolecular Pharmaceutics, 2024
- Selective Uptake of Macromolecules to the Brain in Microfluidics and Animal Models Using the HAVN1 Peptide as a Blood-Brain Barrier ModulatorMolecular Pharmaceutics, 2024
- Exploiting transferrin receptor for delivering drugs across the blood-brain barrierDrug Discovery Today: Technologies, 2016
- The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ɛ-caprolactone) nanoparticlesBiomaterials, 2012
- Effect of Focused Ultrasound Applied With an Ultrasound Contrast Agent on the Tight Junctional Integrity of the Brain Microvascular EndotheliumUltrasound in Medicine & Biology, 2008
- Transport of hydroxyzine and triprolidine across bovine olfactory mucosa: Role of passive diffusion in the direct nose-to-brain uptake of small moleculesInternational Journal of Pharmaceutics, 2005
- Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubblesUltrasound in Medicine & Biology, 2004